该公司的核心技术产品是一系列人工智能医学影像产品，包括MAICOP（人工智能操作平台）、AINS-CARE（神经系统病变磁共振影像辅助诊断软件）、MAICOPBrain（脑部三维可视化图像处理软件）、脑龄评估系统等。基于过去多年发展，和信康已经具备了行业领先的影像AI技术，于2022年被北京市经济和信息化局认定为“专精特新中小企业”，且分别于2019年、2022年获评国家高新技术企业。Meizhong Jiahe and Yiling Group are accelerating the advancement of AI medical applications.
On November 25, 2024, Meizhong Jiahe Group (02453), a Hong Kong-listed company, announced through its subsidiary Beijing Hexin Kang Technology Co., Ltd. (referred to as Beijing Hexin Kang) the successful completion of its Series B financing, raising several tens of millions of yuan. This round of financing was jointly invested by Meizhong Jiahe Group, Yiling Group, and the founder of Hexin Kang. The funds raised will mainly be used to continuously enhance core product research and development and commercialization layout.
Beijing Hexin Kang is an important strategic layout of Meizhong Jiahe Group in the field of artificial intelligence, established in 2015, focusing on improving medical services through AI technology. Its product line covers AI-assisted diagnostic systems for medical imaging, medical imaging diagnostic centers, and medical-grade intelligent detection terminals, aiming to provide accurate diagnostic support and decision-making assistance for medical institutions.
The company's core technology products are a series of AI medical imaging products, including MAICOP (AI Operation Platform), AINS-CARE (Neurological Lesion Magnetic Resonance Imaging Assisted Diagnostic Software), MAICOPBrain (3D Visualization Image Processing Software for the Brain), Brain Age Assessment System, etc. Based on years of development, Hexin Kang has already possessed industry-leading imaging AI technology, recognized in 2022 by the Beijing Economic and Information Bureau as a 'specialized, special and new small and medium-sized enterprise', and awarded the title of national high-tech enterprise in 2019 and 2022 respectively.
Yiling Hospital Management Group has been deeply engaged in the big health industry for many years, forming a comprehensive medical health service industry group themed on health, beauty, and happiness, primarily centered around the medical services industry, spanning preventive medicine, rehabilitation medicine, traditional Chinese medicine chains, internet hospitals, cross-border e-commerce, medical elderly care hotels, medical tourism, and medical real estate, among others. Currently, the Yiling Group owns several medical institutions including the Boao Yiling Life Care Center, Boao Yiling Life Quality Improvement Center, Boao Super Traditional Chinese Medicine Hospital, Yiling Internet Hospital, Yiling Mobile Pre-examination Center, and more than 10 subsidiaries, establishing over 2000 regional service centers and urban reception areas nationwide centered on traditional Chinese medicine outpatient services and health management institutions, making it the rapidly growing international medical tourism chain service organization in China.
Currently, Beijing Hexin Kang is collaborating with Meizhong Jiahe Group and Yiling Group to promote the research and application of large medical models to meet the critical needs in core business processes, membership services, service margin expansion, and operational cost savings. This strong alliance will contribute to the innovation of Hexin Kang's core products, significantly enhancing its market competitiveness, while also creating more market opportunities for the parent company Meizhong Jiahe Group, laying a solid foundation for its future growth potential.
